Home/Rezolute/Brian Roberts, M.D.
BR

Brian Roberts, M.D.

Chief Medical Officer

Rezolute

Rezolute Pipeline

DrugIndicationPhase
Ersodetug (RZ358)Congenital Hyperinsulinism (HI)Phase 3